Toxicology Education

Toxicology education built for the people who actually use it.

From quick clinical insights you can share in a minute to deep-reference guides you'll return to again and again — we produce practical, science-grounded toxicology education for clinicians, drug court professionals, and legal practitioners.

Education Product Lines

Each product serves a different moment in your day — a free pearl to share with a colleague, a newsletter to stay current, a deep-reference guide to get smart on a topic fast, or a live session built for your team.

Product Line 01
📬
ToxSignal
The Clinical Toxicology Newsletter

A regularly published newsletter covering what's happening right now in clinical toxicology — emerging drug threats in the news, regulatory changes in drug testing, lab technology updates, and practice-changing science. Written in plain clinical language for professionals who need to stay informed without having to hunt for it.

Sample · ToxSignal — Issue 02
May 2026
Medetomidine · Cannabis rescheduling · MOUD retention
Alert No FDA reversal agent · detections up 33x since 2023
Policy Cannabis → Schedule III · DOT testing unchanged
Science MOUD benefit extends through 4–5 years
Deadline DOT oral fluid workaround · June 10
Newsletter Email Delivery Free Subscription
Subscribe Free →
Product Line 02
📖
Tox In Focus
Focused Clinical Reference Series

One topic. One well-written document. Tox In Focus delivers 1–2 page reference guides on specific drugs, drug classes, testing technologies, and validity concepts — the resource you reach for when you need to get smart on something fast, or when you need to explain it to someone else.

Sample · Tox In Focus — Vol. 01
Medetomidine
α₂-Adrenergic agonist · Non-opioid sedative · "Rhino tranq"
Detection Not established (illicit) · IV use: <24 hrs
IA Gap Missed by all standard immunoassay panels
Found With Fentanyl · Xylazine
Reversal No FDA-approved agent · Naloxone ineffective
1–2 Page Format Clinical Reference By Request
View the Series →
Product Line 03
💡
Tox Pearls
Quick Clinical Insights — Free to Share

Short, punchy toxicology insights built for the point-of-care moment — or for sharing with a colleague on LinkedIn. Each pearl covers a single concept clearly, in under a minute. Distributed free as a way to get high-quality toxicology thinking into the hands of the clinicians and legal professionals who need it most.

Free Quick Read LinkedIn Friendly
View Tox Pearls →
Product Line 04
🎙️
Tox Talks
Live & Recorded Educational Presentations

Live and recorded presentations covering drug testing science, result interpretation, and clinical applications — delivered for staff teams, program administrators, legal professionals, and professional development audiences. Available as CME/CE where applicable.

Live Sessions Recorded CME / CE
Book a Session →
Free to Download & Share

Tox Pearls

Follow on LinkedIn →
Tox Pearl — No. 02 May 2026
Naloxone Reverses the Apnea. It Does Not Reverse the Medetomidine.
Fentanyl Adulterants · Overdose Response

Medetomidine is now adulterating the illicit fentanyl supply at rapidly increasing rates. Naloxone reverses opioid-driven respiratory depression but cannot reverse medetomidine sedation. No FDA-approved reversal agent exists.

Free Download (PDF)
Tox Pearl — No. 01 May 2026
A Positive Immunoassay Is a Presumptive Result: Not a Diagnosis
Urine Drug Testing

Immunoassay screens detect drug classes by cross-reactivity, not by identifying a specific compound. Learn when a screen result is enough — and when you need LC-MS/MS before you act.

Free Download (PDF)
Who These Resources Serve
🏥
Clinicians & Prescribers

Physicians, NPs, and PAs who need practical guidance on interpreting drug test results, understanding detection windows, and managing complex medication-adherence questions.

⚖️
Drug Court Professionals

Judges, coordinators, probation officers, and program staff who need to understand and confidently apply drug testing evidence in supervision and sanctioning decisions.

🏛️
Legal & Regulatory Professionals

Attorneys, paralegals, and compliance officers who need to understand the science behind drug test evidence well enough to evaluate it, challenge it, or present it in legal proceedings.

Custom Training & Staff Education
Need something built for your team?

We develop and deliver custom training programs for healthcare organizations, drug court programs, and legal teams — tailored to your staff's role, your specific patient population, and your organizational context. Formats range from half-day workshops to multi-module onboarding programs.

Get Started
Let's talk about your education needs.

Whether you're looking for a single reference resource or a comprehensive staff training program — we can help you find the right format for your team and your context.

ToxSignal Newsletter

Get ToxSignal in Your Inbox

The clinical toxicology newsletter — drug trends, regulatory updates, and practice-relevant science, delivered free.

No spam. Unsubscribe anytime.